180 related articles for article (PubMed ID: 9676592)
1. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs.
Théon AP; Feldman EC
J Am Vet Med Assoc; 1998 Jul; 213(2):225-31. PubMed ID: 9676592
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation.
Théon AP; Rodriguez C; Madewell BR
J Am Vet Med Assoc; 1997 Mar; 210(6):778-84. PubMed ID: 9074679
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cobalt 60 radiotherapy in dogs with pituitary-dependent hyperadrenocorticism.
Goossens MM; Feldman EC; Theon AP; Koblik PD
J Am Vet Med Assoc; 1998 Feb; 212(3):374-6. PubMed ID: 9470046
[TBL] [Abstract][Full Text] [Related]
4. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
Nelson RW; Ihle SL; Feldman EC
J Am Vet Med Assoc; 1989 Jun; 194(11):1612-7. PubMed ID: 2753785
[TBL] [Abstract][Full Text] [Related]
5. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989-2005).
Wood FD; Pollard RE; Uerling MR; Feldman EC
J Am Vet Med Assoc; 2007 Oct; 231(7):1081-5. PubMed ID: 17916035
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors and patterns of failure in dogs with periodontal tumors treated with megavoltage irradiation.
Théon AP; Rodriguez C; Griffey S; Madewell BR
J Am Vet Med Assoc; 1997 Mar; 210(6):785-8. PubMed ID: 9074680
[TBL] [Abstract][Full Text] [Related]
8. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990).
Kipperman BS; Feldman EC; Dybdal NO; Nelson RW
J Am Vet Med Assoc; 1992 Sep; 201(5):762-7. PubMed ID: 1328121
[TBL] [Abstract][Full Text] [Related]
9. Effects of radiotherapy on pituitary corticotroph macrotumors in dogs: a retrospective study of 12 cases.
de Fornel P; Delisle F; Devauchelle P; Rosenberg D
Can Vet J; 2007 May; 48(5):481-6. PubMed ID: 17542365
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs.
Duesberg CA; Feldman EC; Nelson RW; Bertoy EH; Dublin AB; Reid MH
J Am Vet Med Assoc; 1995 Mar; 206(5):657-62. PubMed ID: 7744687
[TBL] [Abstract][Full Text] [Related]
11. Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: eight cases (1976-1984).
Sarfaty D; Carrillo JM; Peterson ME
J Am Vet Med Assoc; 1988 Oct; 193(7):854-6. PubMed ID: 3192468
[TBL] [Abstract][Full Text] [Related]
12. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
14. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
J Am Vet Med Assoc; 1999 Oct; 215(7):938-43. PubMed ID: 10511856
[No Abstract] [Full Text] [Related]
16. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
Nelson RW; Feldman EC; Shinsako J
Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
[TBL] [Abstract][Full Text] [Related]
17. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
[TBL] [Abstract][Full Text] [Related]
18. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
Kemppainen RJ; Zenoble RD
J Am Vet Med Assoc; 1985 Aug; 187(3):276-8. PubMed ID: 4030467
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism.
Bertoy EH; Feldman EC; Nelson RW; Duesberg CA; Kass PH; Reid MH; Dublin AB
J Am Vet Med Assoc; 1995 Mar; 206(5):651-6. PubMed ID: 7744686
[TBL] [Abstract][Full Text] [Related]
20. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs.
Kent MS; Bommarito D; Feldman E; Theon AP
J Vet Intern Med; 2007; 21(5):1027-33. PubMed ID: 17939560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
